ALKEM LABORATORIES
Back to Income Statement
|
ALKEM LABORATORIES Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹2,165 Cr | ₹1,796 Cr | ₹984 Cr | ₹1,646 Cr | ₹1,585 Cr |
What is the latest Consolidated Net Profit of ALKEM LABORATORIES ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹2,165 Cr |
| Mar2025 | ₹1,796 Cr |
| Mar2024 | ₹984 Cr |
| Mar2023 | ₹1,646 Cr |
| Mar2022 | ₹1,585 Cr |
How is Consolidated Net Profit of ALKEM LABORATORIES Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,165 Cr | 20.59 | |
| Mar2025 | ₹1,796 Cr | 82.47 | |
| Mar2024 | ₹984 Cr | -40.19 | |
| Mar2023 | ₹1,646 Cr | 3.82 | |
| Mar2022 | ₹1,585 Cr | - | |
Compare Consolidated Net Profit of peers of ALKEM LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALKEM LABORATORIES | ₹60,686.8 Cr | 1.8% | -3.7% | -7.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,803.0 Cr | 0.2% | -5.2% | 4.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹253,833.0 Cr | 4.9% | -0.5% | 43.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,461.0 Cr | -1.1% | -8.5% | 28.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,463.0 Cr | 7.8% | 11% | 1.2% | Stock Analytics | |
| CIPLA | ₹109,870.0 Cr | 2.3% | -2.7% | -18.9% | Stock Analytics | |
ALKEM LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALKEM LABORATORIES | 1.8% |
-3.7% |
-7.1% |
| SENSEX | -0.6% |
-0.5% |
-13.2% |
You may also like the below Video Courses